{"id":3909,"date":"2026-10-26T09:00:00","date_gmt":"2026-10-26T13:00:00","guid":{"rendered":"https:\/\/www.insilens.com\/?p=3909"},"modified":"2026-10-26T19:30:35","modified_gmt":"2026-10-26T23:30:35","slug":"rnf126-glue-degrades-a-cancer-associated-gpcr-in-cells","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=3909","title":{"rendered":"RNF126 Glue Degrades a Cancer Associated GPCR in Cells"},"content":{"rendered":"

\"\"<\/p>\n

Company<\/strong><\/p>\n

Hebrew University of Jerusalem (Kashkush and colleagues)<\/p>\n

Event Type<\/strong><\/p>\n

Peer-reviewed publication<\/p>\n

Modality<\/strong><\/p>\n

Covalent molecular-glue degrader (RNF126-recruiting)<\/p>\n

Asset<\/strong><\/p>\n

MG-CB2<\/p>\n

Target<\/strong><\/p>\n

Cannabinoid receptor 1 (CB1R)<\/p>\n

Disease Area<\/strong><\/p>\n

Cancer (breast and liver cell models)<\/p>\n

Summary<\/h4>\n

An online-first, peer-reviewed npj Drug Discovery study dated 26 October reports covalent molecular-glue degradation of cannabinoid receptor 1, a membrane GPCR, in two cancer cell models. The work broadens a possible degrader target class but remains early cell-level pharmacology.<\/p>\n

Kashkush and colleagues converted a rimonabant-derived CB1R binder into electrophilic candidate glues. Lead MG-CB2 produced time- and concentration-dependent CB1R depletion in MCF-7 breast and HepG2 liver cancer cells. Proteasome blockade and RNF126 knockdown prevented loss; rimonabant competition and thermal-shift assays supported target engagement. In HepG2 cells maximal depletion was about 95% at 20 micromolar, with DC50 near 6 micromolar. Signaling, viability and migration changed in treated cells. DCAF16-recruiting analogs did not degrade CB1R. No animal antitumor efficacy or human dosing was reported.<\/p>\n

Deep Analysis<\/h4>\n

A GPCR degrader is mechanistically distinctive because many induced-proximity programs focus on soluble intracellular proteins. Orthogonal proteasome, ligase and competition experiments make the cellular mechanism more credible than an isolated Western blot. But micromolar potency and an electrophilic covalent handle raise exposure, promiscuous cysteine binding and off-target risks. Cancer-cell viability effects need rescue with degradation-resistant CB1R and comparison against nondegrading antagonists, because receptor antagonism or general electrophile stress could account for part of the phenotype. Tissue access, CNS penetration or avoidance, PK\/PD, normal-tissue CB1R functions, in-vivo therapeutic window, durability, reversibility, immunogenicity, manufacturability and freedom to operate are not established. Target abundance in patient tumors and dependence across molecular subtypes require validation before startup or licensing claims are strong.<\/p>\n

Company and Product Background<\/h4>\n

CB1R is a cannabinoid-responsive GPCR implicated in signaling in some tumor models. RNF126 is an E3 ubiquitin ligase. A molecular glue promotes a protein interaction that marks the target for proteasomal destruction; this differs from occupancy-only receptor antagonism.<\/p>\n

Signal Extraction<\/h4>\n
    \n
  • Interpretation A:<\/strong> RNF126 recruitment opens a tractable route to GPCR degradation; genetic and chemical controls support it.<\/li>\n
  • Interpretation B:<\/strong> high-concentration covalent chemistry creates nonspecific cellular stress; micromolar DC50 and absent in-vivo evidence support caution.<\/li>\n
  • Upgrade:<\/strong> clean proteomics, structural ternary-complex proof, receptor rescue, potent analogs and animal tumor efficacy at tolerated exposure. Downgrade:<\/strong> broad proteome reactivity or normal-tissue toxicity. Falsification:<\/strong> selective CB1R degradation cannot be achieved at pharmacologically plausible exposures.<\/li>\n<\/ul>\n

    InSilens Take<\/h4>\n

    Inference: the paper is a platform-level proof of concept for transmembrane GPCR degradation, with substantial optimization required before therapeutic relevance can be claimed.<\/p>\n

    Signal Assessment<\/h4>\n

    Signal Importance: 3 of 5. Signal Direction: uncertain for translation. Confidence in Facts: moderate (reported cell findings). Confidence in Interpretation: low (therapeutic).<\/p>\n","protected":false},"excerpt":{"rendered":"

    An online-first, peer-reviewed npj Drug Discovery study dated 26 October reports covalent molecular-glue degradation of cannabinoid receptor 1, a membrane GPCR, in two cancer cell models. The work broadens a possible degrader target class…<\/p>\n","protected":false},"author":1,"featured_media":3917,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[1224,380,1226,1225,275],"class_list":["post-3909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology-modalities","tag-cb1r","tag-molecular-glue","tag-npj-drug-discovery","tag-rnf126","tag-targeted-protein-degradation"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3909"}],"version-history":[{"count":1,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3909\/revisions"}],"predecessor-version":[{"id":3925,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3909\/revisions\/3925"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/3917"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}